Labiotech.eu - Europe's leading Biotech News Website

Latest Posts

Asarina Sepranolone PMDD Phase IIa

More News! 3 Apr 2017

First Treatment for Severe Premenstrual Syndrome Clears Phase II

Swedish Asarina Pharma has announced positive results of a Phase IIa study for the treatment of Premenstrual Dysphoric Disorder (PMDD). With only a single product candidate in its pipeline, Asarina Pharma is focusing on the development of the first potential therapy for the treatment of PMDD, a severe and disabling form of premenstrual syndrome that affects about 5% of […]

April 3, 2017 - 3 minutesmins - By Melanie De Almeida

Oxitec Zika Dengue Brazil 1

News and Trends 3 Apr 2017

New Results Show GM Mosquitoes Keep Dengue and Zika at Bay in Brazil

In its second year, Oxitec has reduced the mosquito population in a Brazilian neighborhood by 81%, demonstrating the long-term potential of GM insects. Oxitec is a spin-out from the University of Oxford that fights infectious disease with genetically-engineered mosquitoes that produce inviable offspring. The company has already made field trials in the Cayman Islands, Panama, Brazil, […]

April 3, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

vladitto glass ceiling fi

News and Trends 3 Apr 2017

UPDATE: First Woman CEO of a Global Drug Maker starts at GSK today

GSK has punched a hole in the glass ceiling with its appointment of a new female CEO, Emma Walmsley. It’s up to her to reinvigorate the company. Emma Walmsley may be the most powerful woman in corporate Britain. The Oxford grad and L’Oreal veteran has just been crowned CEO of the pharma giant GSK: a marketing […]

April 3, 2017 - 2 minutesmins - By Evelyn Warner

Bruce Rolff collage

Interview 3 Apr 2017

Meet the Co-Founder who says DNA is the Next Silicon

DNA Script opens the door to a whole new age of manufacturing synthetic DNA. Thomas Ybert, was only 30 when he co-founded the company – here’s his story! Based in Paris, DNA Script produces synthetic DNA using a proprietary template-free enzymatic technology. Most of the manufactured DNA is currently synthesized by chemical means, but this startup […]

April 3, 2017 - 5 minutesmins - By External Contributor

jacob remin biomining tech

More News! 1 Apr 2017

Will we Rely on Biomining to Build the Tech Devices of the Future?

The Danish artist Jacob Remin explores how biotech might be essential if we want to keep building smartphones and laptops. Computers, tablets, phones, television screens… we take our electronic devices for granted. However, the rapidly increasing demand might not be possible to meet because of rare earth elements, a series of rare metals that are […]

April 1, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

deinove synbio cosmetics skin care

News and Trends 31 Mar 2017

French Synbio Company gets ready to break into Cosmetics

After biofuels and carotenoids, Deinove is now moving forward on the cosmetics front. Its engineered microbes can produce a number of interesting chemicals for skin care, and Deinove plans to bring them to market until the end of 2018. Deinove is a key synbio biotech in France and has found a wide range of applications for […]

March 31, 2017 - 3 minutesmins - By Denise Neves Gameiro

ADVERTISEMENT

Research Immune System Age

News and Trends 30 Mar 2017

New Clues on How the Immune System Weakens with Age

By analyzing the responses of individual immune cells, a new study in Science provides new insights into the decline of the immune system with age. In a collaborative effort, researchers from the European Bioinformatics Institute (EMBL-EBI), University of Cambridge, the Wellcome Trust Sanger Institute and the Cancer Research UK–Cambridge Institute (CRUK-CI) have shed light on a […]

March 30, 2017 - 2 minutesmins - By Melanie De Almeida

Merck Avillion nanobody psoriasis

News and Trends 30 Mar 2017

Merck Outsources the Development of its Nanobody for Psoriasis

Merck has signed a new agreement with Avillion for its nanobody against psoriasis. Avillion will advance the nanobody from Phase II through Phase III. As part of several partnerships between Merck and the unbeaten nanobody biotech Ablynx, Merck recently cleared Phase Ib with its llama-inspired nanobody targeting the cytokines IL-17 A/F for the treatment of plaque psoriasis. The antibody […]

March 30, 2017 - 3 minutesmins - By Melanie De Almeida

Regeneron Sanofi dupilumab Atopic Dermatitis

News and Trends 29 Mar 2017

Get Ready for One of the Biggest New Drug Approvals of the Year

After Praluent, Sanofi and Regeneron have now scored their next drug approval with dupilumab, an antibody for the treatment of atopic dermatitis. With three placebo-controlled clinical trials enrolling a total of 2119 adult participants, Sanofi and its partner Regeneron were able to convince the FDA of their new biological for the treatment of atopic dermatitis. The product of this expansive effort comes […]

March 29, 2017 - 3 minutesmins - By Melanie De Almeida

shutterstock 609449708

More News! 29 Mar 2017

More “FDA Love” for Cannabis Company with Orphan Drug Designation

Last year was a doozy for biotech, but it was spectacular for GW Pharmaceuticals. Its streak continues with more special treatment. GW Pharmaceuticals, which is developing epilepsy treatments from marijuana, is making a name for itself not just as “that company” turning a recreational drug into medical ones; the company was also one of 2016’s surprise successes — its […]

March 29, 2017 - 2 minutesmins - By Evelyn Warner

Lysogene gene therapy Sanfillipo A obs study

News and Trends 29 Mar 2017

French Gene Therapy Biotech Gets Ready for Phase II/III

Lysogene has crunched the numbers on its observational study for Sanfillipo A – now the company can move into the final phase for its Sanfilippo A therapy. Lysogene is a French biotech specializing in gene therapy of rare CNS diseases. Its lead asset is a gene therapy for the treatment of the rare genetic disorder […]

March 29, 2017 - 3 minutesmins - By Melanie De Almeida

stoatphoto 1

News and Trends 29 Mar 2017

Looking to Patent your Biotech Invention? Here’s What You Need to Know

So you’ve made a discovery you want to protect or an invention you want to commercialize. How do you claim intellectual property? Patents are the most relevant kind of intellectual property protection for technology-driven industries, particularly high-tech startups. They grant intellectual property rights covering technical inventions and relate to compositions, processes or methods of making these, or their use for a particular purpose. More […]

March 29, 2017 - 4 minutesmins - By External Contributor

ADVERTISEMENT